Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ala”

271 pharma patents match "ala" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 7 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "ala" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “ala” · 30,257 patents in full index Clear search

  1. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted

  2. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  3. US 9321834

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  4. US 9254316

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

  5. US 9249179

    Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA

    Arrowhead Madison, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  6. US 9248131

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  7. US 9238653

    Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase

    The Board of Regents of the University of Texas System · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  8. US 9216983

    Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  9. US 9200090

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  10. US 9194011

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  11. US 9133461

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  12. US 9096653

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  13. CA 2866861

    TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

    AIR LIQUIDE SANTE INT [FR] · Granted May 26, 2015 · Expires May 21, 2035

    granted

  14. US 9028842

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Northwestern University · Granted May 12, 2015 · Expires May 7, 2035

    granted

  15. US 9023809

    Phenylalanine dipeptide derivatives, compositions and use thereof

    302 Hospital of PLA, China · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  16. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  17. US 8999987

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  18. US 8940513

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  19. AU 2013283318

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH [DE] · Granted Jan 22, 2015 · Expires Jan 17, 2035

    granted

  20. US 8937178

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  21. US 8900599

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  22. US 8852598

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  23. US 8846627

    Method for treatment of malaria

    East China University of Science and Technology · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  24. US 8835491

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.